| Cat. No. | Product Name | Field of Application | Chemical Structure |
|---|---|---|---|
| DCC0122 | (s)-fty720 Vinylphosphonate | Novel allosteric Sphingosine kinase 1 (SK1) inhibitor |
|
| DCC0123 | (s)-gyramide A | Novel bacterial DNA gyrase inhibitor, exhibiting antimicrobial activity and inhibiting bacterial cell division |
|
| DCC0124 | (s)-nbp | More active enantiomer of NBP; Neuroprotective agent used clinically in the acute phase of ischemic stroke, improving functional recovery and promoting angiogenesis and collateral vessel circulation |
|
| DCC0125 | (s)-ncc122 | Potent D1 dopamine ligand |
|
| DCC0126 | (s)-pomalidomide | Inhibitor of angiogenesis and growth of B-cell neoplasias, inducing complete regressions of Burkitt's lymphoma cell tumors |
|
| DCC0127 | (s)-retro-1.1 | Novel potent inhibitor of Shiga toxin (STX) cytotoxicity |
|
| DCC0128 | (s)-syaf030 | Novel Potent Antagonist of the Human A 2B Adenosine Receptor |
|
| DCC0129 | (s)-syaf080 | Novel Potent Antagonist of the Human A 2B Adenosine Receptor |
|
| DCC0130 | (wrk)4 | Novel Antimicrobial Peptide with Repeating Unit against Multidrug-Resistant Bacteria |
|
| DCC0131 | (wrk)5 | Novel Antimicrobial Peptide with Repeating Unit against Multidrug-Resistant Bacteria |
|
| DCC0132 | (z)-5-tetradecen-1-ol | Novel ligand of the mouse orphan odorant receptor Olfr288 |
|
| DCC0133 | [dmt1,5]n/ofq(1-13)-nh2 | Novel highly potent dual NOP/mu receptor peptide agonist, exerting antitussive effects in an in vivo model of cough |
|
| DCC0134 | [d-trp]cj-15208 | Short-duration κ opioid receptor antagonist with weak KOR agonist activity |
|
| DCC0135 | [n9a]lvia | Novel α-Conotoxin LvIA Analogue, highly selectively trgeting α3β2 nicotinic acetylcholine receptors with >2000-fold higher selectivity than LvIA |
|
| DCC0136 | 002-04-kk | Novel inhibitor of the biosynthesis of DNA, RNA and proteins; Antimicrobial agent |
|
| DCC0137 | 0026-59-kk | Novel inhibitor of the biosynthesis of DNA, RNA and proteins; Antimicrobial agent |
|
| DCC0138 | 1(r)-(trifluoromethyl)oleyl Alcohol | Novel potent ferroptosis inhibitor |
|
| DCC0139 | 1,3,6-trihydroxyxanthone | Anti-androgenic, Antimicrobial, and anticancer agent |
|
| DCC0140 | 1,4-nhq | Inhibitor of the Cdc42-PBD interaction, blocking the association of Cdc42 with the PBD |
|
| DCC0141 | 1.16-hexadecanedithiol | Long chain dithiol for self-assembled monolayers (SAMs) in sensors |
|
| DCC0142 | 10074-a4 | Novel Myc-Max-specific inhibitor |
|
| DCC0143 | 10-fthf | Donor of formyl groups in anabolism used as a substrate in formyltransferase reactions, which is important in purine biosynthesis |
|
| DCC0144 | 11-deoxy-pgf2a | Selective activator of TREK-2 channels, stimulating DRG c-fiber nociceptor K2P currents and limiting calcium influx |
|
| DCC0145 | 11-oxo-ete | Cellular antiproliferative agent, inhibiting BrdU incorporation acrossing multiple cell lines with varying potency |
|
| DCC0146 | 11ß-hsd1 Inhibitor 544 | Potent inhibitor of both mouse and human 11β-HSD1 |
|
| DCC0147 | 11ßhsd1-in-1 | Novel potent and selective inhibitor of 11ß-hydroxysteroid dehydrogenase type 1 enzyme |
|
| DCC0148 | 12-crown-4 | Aß40 fibril disrupter |
|
| DCC0149 | 12-hydroxynevirapine | Metabolite of Nevirapine |
|
| DCC0150 | 12oh-ja | Novel regulator of plant growth and immunity, promoting flower and tuber development but prevents induction of JA signaling, plant defense or both |
|
| DCC0151 | 13b-1c | Potent highly active irreversible inhibitor of myeloperoxidase (MPO) |
|
